TOP STORIES
respiratory

ERS 2021: Australian context, international perspectives

Join the limbic and a panel of Australian and international experts to discuss the highlights from ERS International Congress 2021 and implications for Australian clinical practice. Viewers will have the opportunity to...

Join the limbic and a panel of Australian and international experts to discuss the highlights from ERS International Congress 2021...

Read more

Obesity linked to poor response to inhaled steroids in children with asthma 

Children with asthma who are overweight or obese may be less likely to respond to treatment with inhaled steroids potentially increasing their risk of asthma attack, according to findings of an observational study presented at ERS 2021. The research, led by...

Children with asthma who are overweight or obese may be less likely to respond to treatment with inhaled steroids potentially...

News in brief: Inhaler boycott possible after tobacco company takeover, TSANZ warns; Climate change to worsen COPD symptoms; Healthcare worker vaccination reduces COVID-19 transmission;

Inhaler boycott possible after tobacco company takeover, TSANZ warns Respiratory specialists may boycott COPD inhalers that use Vectura technology if the company is taken over by tobacco company Philip Morris International, according to Thoracic Society of Australia and New Zealand chief...

Inhaler boycott possible after tobacco company takeover, TSANZ warns Respiratory specialists may boycott COPD inhalers that use Vectura technology if the...

ICS therapy shows most CV benefit in COPD patients with eosinophilia 

COPD patients with higher levels of eosinophils are more at risk of experiencing a cardiac event if not receiving an inhaled corticosteroid (ICS) as part of their therapy, according to a post hoc analysis of data from the ETHOS trial. Presenting...

COPD patients with higher levels of eosinophils are more at risk of experiencing a cardiac event if not receiving an...